MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

[1]  A. Lees,et al.  Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.

[2]  H. Curran,et al.  Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. , 1997, Addiction.

[3]  G. Goodwin,et al.  Ecstasy and neurodegeneration , 1996, BMJ.

[4]  A. Forsyth,et al.  Places and patterns of drug use in the Scottish dance scene. , 1996, Addiction.

[5]  R. Poland,et al.  Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations , 1995, Behavioural Brain Research.

[6]  F. Schifano,et al.  MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series , 1994, Biological Psychiatry.

[7]  U. McCann,et al.  3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. , 1994, Addiction.

[8]  Y. Shaham,et al.  Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.

[9]  N. Solowij.  Ecstasy (3,4-methylenedioxymethamphetamine) , 1993 .

[10]  W. Hall,et al.  Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. , 1992, British journal of addiction.

[11]  J. Henry.  Ecstasy and the dance of death. , 1992, BMJ.

[12]  S. Pallanti,et al.  MDMA (Ecstasy) precipitation of panic disorder , 1992, Biological Psychiatry.

[13]  F. Schifano.  Chronic atypical psychosis associated with MDMA ("ecstasy") abuse , 1991, The Lancet.

[14]  U. McCann,et al.  Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users. , 1991, Journal of clinical psychopharmacology.

[15]  J. Langston,et al.  Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations a , 1990, Annals of the New York Academy of Sciences.

[16]  S. Peroutka,et al.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[17]  G. Hanson,et al.  Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. , 1988, The Journal of pharmacology and experimental therapeutics.

[18]  Peroutka Sj.  Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987 .

[19]  J. Krystal,et al.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? , 1992, The American journal of drug and alcohol abuse.

[20]  J. Krystal,et al.  Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. , 1989, Archives of general psychiatry.

[21]  S. Peroutka.  Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987, The New England journal of medicine.

[22]  R. Michels,et al.  Diagnostic and Statistical Manual of Mental Disorders, 3rd ed , 1981 .